Jiutian Chemical Group Limited (C8R) AI Stock Analysis

• Market Cap: S$53.69M
• Dividend Yield: N/A
• Average Volume (3M): 3.60M
• Price to Earnings (P/E): ―
• Beta (1Y): 1.10
• Revenue Growth: -60.43%
• EPS Growth: 57.93%
• Country: SG
• Employees: N/A
• Sector: Basic Materials
• Sector Strength: 67
• Industry: Chemicals
• EPS (TTM): N/A
• Shares Outstanding: 1,988,444,000
• 10 Day Avg. Volume: 7,942,320
• 30 Day Avg. Volume: 3,599,956
• PEG Ratio: N/A
• Price to Book (P/B): 0.48
• Price to Sales (P/S): 0.00
• P/FCF Ratio: -1.74
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: Moderate Sell
• Number of Analyst Covering: 0

• Rating: 43 Neutral
• Price Target: S$0.00 ▼(-100.00%Downside)

Jiutian Chemical Group Limited's overall stock score is primarily influenced by its poor financial performance, which is the most significant factor. Technical analysis provides some short-term positive momentum, but the extremely high RSI suggests potential overvaluation. The negative P/E ratio highlights serious valuation concerns, further impacting the score negatively. With no earnings call insights or corporate events to adjust the analysis, the stock's outlook remains challenging.

Jiutian Chemical Group Limited Business Overview & Revenue Model

Company Description

Jiutian Chemical Group Limited (C8R) is a Singapore-based company primarily engaged in the manufacturing and distribution of chemical products. The company operates in the industrial chemical sector, focusing on the production of dimethylformamide (DMF) and methylamine, which are widely used as industrial solvents and in the manufacturing of various products. Jiutian Chemical's operations are based in China, where it leverages local resources and expertise to maintain a competitive edge in the chemical manufacturing industry.

How the Company Makes Money

Jiutian Chemical Group Limited generates revenue through the production and sale of its core chemical products, dimethylformamide (DMF) and methylamine. These chemicals are essential components in multiple industries, including pharmaceuticals, agriculture, textiles, and electronics, serving as solvents and intermediates in manufacturing processes. The company earns money by selling these products directly to industrial customers and distributors who require them for their manufacturing needs. Additionally, Jiutian Chemical may engage in partnerships or supply agreements with other industrial players, which can provide stable and recurring revenue streams. Factors such as global demand for chemicals, raw material costs, and production efficiency significantly impact the company's earnings.

Jiutian Chemical Group Limited Financial Statement Overview

Summary

Jiutian Chemical Group Limited is facing significant financial difficulties, with declining revenue, profitability, and cash flow. The income statement reveals critical weaknesses in generating profits, while the balance sheet indicates moderate leverage but declining equity. Cash flow challenges further exacerbate the company's financial instability, raising concerns about its ability to sustain operations without strategic interventions.

Income Statement

Jiutian Chemical Group Limited has experienced a significant decline in revenue and profitability over the past years. The gross profit margin and net profit margin have turned negative, indicating that the company is not covering its costs. The revenue growth rate has decreased significantly, with a notable drop in total revenue from 2022 to 2023. EBIT and EBITDA margins are also negative, highlighting poor operational performance. Overall, the company's income statement presents substantial financial challenges.

Balance Sheet

The balance sheet of Jiutian Chemical Group Limited shows moderate leverage with a debt-to-equity ratio that has improved slightly over the years. However, the equity ratio has decreased, indicating a decline in the proportion of assets financed by equity. Return on Equity (ROE) has become negative due to consecutive net losses. Although cash reserves are relatively strong, the overall stability is compromised by declining equity and profitability.

Cash Flow

The cash flow situation is concerning, with free cash flow experiencing a negative growth rate and operating cash flow consistently negative over the recent years. The operating cash flow to net income ratio is unfavorable, reflecting inefficiencies in converting income to cash. Free cash flow to net income ratio is also negative, indicating cash flow issues that could impact future operations.

Breakdown	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Income Statement
Total Revenue	243.76M	598.56M	2.43B	2.17B	1.15B
Gross Profit	-82.26M	-260.18M	708.41M	675.62M	274.77M
EBITDA	-118.22M	-321.76M	696.61M	632.38M	259.93M
Net Income	-147.80M	-344.64M	490.50M	324.90M	173.69M
Balance Sheet
Total Assets	1.05B	1.29B	1.99B	1.89B	1.43B
Cash, Cash Equivalents and Short-Term Investments	400.41M	529.62M	1.11B	773.55M	259.73M
Total Debt	289.32M	265.88M	134.64M	228.18M	344.30M
Total Liabilities	427.02M	523.23M	764.65M	1.08B	911.93M
Stockholders Equity	618.04M	765.84M	1.22B	816.21M	524.74M
Cash Flow
Free Cash Flow	-171.63M	-511.23M	424.05M	633.54M	122.69M
Operating Cash Flow	-81.58M	-385.65M	434.01M	655.81M	129.02M
Investing Cash Flow	-89.54M	-125.70M	-9.85M	-27.68M	-10.90M
Financing Cash Flow	32.87M	-732.00K	-95.52M	-110.89M	5.67M

Jiutian Chemical Group Limited Technical Analysis

• Technical Analysis Sentiment: Positive
• Last Price: 0.03
• 50DMA: Positive
• 100DMA: Positive
• 200DMA: Positive
• MACD: Negative
• RSI: Negative
• STOCH: Negative

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For SG:C8R, the sentiment is Positive. The current price of 0.03 is above the 20-day moving average (MA) of 0.02, above the 50-day MA of 0.02, and above the 200-day MA of 0.03, indicating a bullish trend. The MACD of <0.01 indicates Negative momentum. The RSI at 99.20 is Negative, neither overbought nor oversold. The STOCH value of 116.67 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for SG:C8R.

Jiutian Chemical Group Limited Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
Sector *	63 Neutral	$10.49B	10.77	1.52%	2.68%	2.24%	-33.79%
C8R	43 Neutral	S$53.69M	―	-21.30%	―	-60.43%	57.93%
C05	―	S$41.77M	5.85	-17.75%	2.73%	―	―
5DS	―	S$53.32M	6.75	14.57%	2.50%	―	―
A55	―	S$54.32M	134.55	0.37%	3.38%	―	―
BEI	―	S$52.45M	23.56	3.88%	5.08%	―	―
Y8E	―	S$33.12M	―	-10.42%	―	―	―

Jiutian Chemical Group Limited Corporate Events

Jiutian Chemical Faces Arbitration Over Subsidiary Investment Loss

Jiutian Chemical Group Limited has received a notice of arbitration from a minority shareholder of its former subsidiary, Changzhou Jiutian Xiean Chemical Co., Ltd, which is undergoing creditor’s voluntary liquidation. The arbitration, filed with the Shanghai International Arbitration Center, involves a compensation claim of RMB 2 million for alleged investment losses. The company is reviewing the claim with legal advisors and will update shareholders on any significant developments, advising caution in dealing with its securities.

Jiutian Chemical Extends Long-Stop Date for Synthetic Ammonia Project

Jiutian Chemical Group Limited has announced a third extension of the Long-Stop Date for its Framework Agreement and Synthetic Ammonia Project Transfer Agreement with Anyang Chemical Industry Group Co., Ltd. The extension, now set for December 31, 2025, is necessary to fulfill certain conditions precedent. The company has not reported significant developments since its last update and advises shareholders to exercise caution with their securities.

Jiutian Chemical Group Holds Twentieth AGM

Jiutian Chemical Group Limited held its Twentieth Annual General Meeting at Voco Orchard Singapore, where the Board of Directors and key company officials were present. The meeting was chaired by Executive Director Mr. Lee Chee Seng and addressed shareholder questions regarding resolutions, with responses published on SGXNet prior to the meeting.